Abstract:CO2 microbubbles (MBs) were explored as smart agent in suppressing tumors. CO2 MBs can be massively produced from the decomposition of an effervescent disintegrant in water. However, the explosive decomposing of the effervescent disintegrant in water will extremely limit its therapeutic applications. The short retention duration of CO2 MBs in blood and the tiny quality of MBs that can leak into tumor sites also severely decrease the tumor therapy efficiency. In this research, a multifunctional poly(lactic-co-glycolic acid) (PLGA)-based solid implant was facilely in situ constructed within tumors based on the liquid-solid phase transition of hydrophobic PLGA/effervescent disintegrant/doxorubicin (DOX) (denoted as PED) oleosol, to effectively control the decomposition of the effervescent disintegrant and increase the accumulation of MBs in the tumor site. The formed PED implant could simultaneously function as a high intensity focused ultrasound (HIFU) enhancement agent and a drug delivery platform featured with HIFU-responsive DOX and spontaneous MBs releasing characteristics. Without HIFU treatment, the hydrophobic PLGA will prevent the contacting of effervescent disintegrant or DOX with water. Under HIFU treatment, water could easily diffuse into the PED implant and thus DOX release, effervescent disintegrant decomposition and CO2 release will be switched on. These CO2 MBs can oscillate with the external focused ultrasound and enhance the mechanical and cavitation effect of focused ultrasound, resulting in an enhanced tumor HIFU ablation towards a VX2 tumor-bearing New Zealand White rabbit. Importantly, it is difficult for effervescent disintegrant and DOX to enter the bloodstream in quantity, therefore, the utilization of CO2 MBs and DOX can be increased and the in vivo biosafety of the implant can be guaranteed. The developed PED implant features easy fabrication, low cost, and excellent in vivo hemo-/histo-compatibility, and holds promising potential for future clinical translation for localized tumor therapy.

A Floating Hydrogel System Capable of Generating CO2 Bubbles to Diminish Urinary Obstruction after Intravesical Instillation

Floating Hydrogel With Self-Generating Micro-Bubbles For Intravesical Instillation

In Situ Floating Hydrogel for Intravesical Delivery of Adriamycin Without Blocking Urinary Tract

Visualized intravesical floating hydrogel encapsulating vaporized perfluoropentane for controlled drug release.

Long-Term Retention Microbubbles with Three-Layer Structure for Floating Intravesical Instillation Delivery.

Polysaccharide based supramolecular injectable hydrogels for in situ treatment of bladder cancer

Hydrogel: a new material for intravesical drug delivery after bladder cancer surgery

A mucoadhesive-to-penetrating nanomotors-in-hydrogel system for urothelium-oriented intravesical drug delivery

Injectable 2D-MoS2-integrated adhesive hydrogel for NIR-triggered photothermal and drug-delivery implant in colorectal cancer therapy

Injectable 2D-Mos 2 -Integrated Bioadhesive Hydrogel As Photothermal-Derived and Drug-Delivery Implant for Colorectal Cancer Therapy

Encapsulation of hydroxycamptothecin within porous and hollow poly(l-lactide- co -ε-caprolactone) microspheres as a floating delivery system for intravesical instillation

Intravesical Hydrogels As Drug Reservoirs

One-Step In Situ Self-Assembly of Biodegradable Films for Long-Term Intravesical Bladder Cancer Therapy

Phase-changeable and bubble-releasing implants for highly efficient HIFU-responsive tumor surgery and chemotherapy

A Pure Molecular Drug Hydrogel for Post-Surgical Cancer Treatment

Delivering instilled hydrophobic drug to the bladder by a cationic nanoparticle and thermo-sensitive hydrogel composite system.

Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation.

Hydrogel-based formulations for urothelial cancer therapy

NIR-II light powered hydrogel nanomotor for intravesical instillation with enhanced bladder cancer therapy

Fluorinated Polymer Mediated Transmucosal Peptide Delivery for Intravesical Instillation Therapy of Bladder Cancer

Injectable Zwitterionic Physical Hydrogel with Enhanced Chemodynamic Therapy and Tumor Microenvironment Remodeling Properties for Synergistic Anticancer Therapy